Medical Care

Global Herpes Zoster Treatment Market Insights, Forecast to 2030

Herpes Zoster, also known as zoster or shingles, is a viral disease characterized by a painful skin rash with blisters in a localized area. Typically the rash occurs in a single, wide stripe either on the left or right side of the body or face. Two to four days before the rash occurs there may be tingling or local pain in the area. Otherwise there are typically few symptoms though some may have fever, headache, or feel tired. The rash usually heals within two to four weeks; however, some people develop ongoing nerve pain which can last for months or years, a condition called postherpetic neuralgia (PHN). In those with poor immune function the rash may occur widely. If the rash involves the eye, vision loss may occur.
Market Analysis and Insights: Global Herpes Zoster Treatment Market
The global Herpes Zoster Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Herpes Zoster Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Herpes Zoster Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Herpes Zoster Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Herpes Zoster Treatment include Roche, Novartis, Merck, GlaxoSmithKline, Abbott Laboratories, Astellas Pharma, Bausch Health Companies, Teva Pharmaceutical and Foamix Pharmaceuticals, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Herpes Zoster Treatment is widely used in various fields, such as Hospitals, Clinics and Home Care Settings,, etc. Hospitals provides greatest supports to the Herpes Zoster Treatment industry development. In 2023, global % revenue of Herpes Zoster Treatment went into Hospitals filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Herpes Zoster Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Herpes Zoster Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Herpes Zoster Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Herpes Zoster Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Herpes Zoster Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Herpes Zoster Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Roche
Novartis
Merck
GlaxoSmithKline
Abbott Laboratories
Astellas Pharma
Bausch Health Companies
Teva Pharmaceutical
Foamix Pharmaceuticals
Segment by Type
Oral
Topical
Others
Segment by Application
Hospitals
Clinics
Home Care Settings
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Herpes Zoster Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Herpes Zoster Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Herpes Zoster Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Herpes Zoster Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Topical
1.2.4 Others
1.3 Market by Application
1.3.1 Global Herpes Zoster Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care Settings
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Herpes Zoster Treatment Market Perspective (2019-2030)
2.2 Global Herpes Zoster Treatment Growth Trends by Region
2.2.1 Herpes Zoster Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Herpes Zoster Treatment Historic Market Size by Region (2019-2024)
2.2.3 Herpes Zoster Treatment Forecasted Market Size by Region (2025-2030)
2.3 Herpes Zoster Treatment Market Dynamics
2.3.1 Herpes Zoster Treatment Industry Trends
2.3.2 Herpes Zoster Treatment Market Drivers
2.3.3 Herpes Zoster Treatment Market Challenges
2.3.4 Herpes Zoster Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Herpes Zoster Treatment by Players
3.1.1 Global Herpes Zoster Treatment Revenue by Players (2019-2024)
3.1.2 Global Herpes Zoster Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Herpes Zoster Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Herpes Zoster Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Herpes Zoster Treatment Market Concentration Ratio
3.4.1 Global Herpes Zoster Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Herpes Zoster Treatment Revenue in 2023
3.5 Global Key Players of Herpes Zoster Treatment Head office and Area Served
3.6 Global Key Players of Herpes Zoster Treatment, Product and Application
3.7 Global Key Players of Herpes Zoster Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Herpes Zoster Treatment Breakdown Data by Type
4.1 Global Herpes Zoster Treatment Historic Market Size by Type (2019-2024)
4.2 Global Herpes Zoster Treatment Forecasted Market Size by Type (2025-2030)
5 Herpes Zoster Treatment Breakdown Data by Application
5.1 Global Herpes Zoster Treatment Historic Market Size by Application (2019-2024)
5.2 Global Herpes Zoster Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Herpes Zoster Treatment Market Size (2019-2030)
6.2 North America Herpes Zoster Treatment Market Size by Type
6.2.1 North America Herpes Zoster Treatment Market Size by Type (2019-2024)
6.2.2 North America Herpes Zoster Treatment Market Size by Type (2025-2030)
6.2.3 North America Herpes Zoster Treatment Market Share by Type (2019-2030)
6.3 North America Herpes Zoster Treatment Market Size by Application
6.3.1 North America Herpes Zoster Treatment Market Size by Application (2019-2024)
6.3.2 North America Herpes Zoster Treatment Market Size by Application (2025-2030)
6.3.3 North America Herpes Zoster Treatment Market Share by Application (2019-2030)
6.4 North America Herpes Zoster Treatment Market Size by Country
6.4.1 North America Herpes Zoster Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Herpes Zoster Treatment Market Size by Country (2019-2024)
6.4.3 North America Herpes Zoster Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Herpes Zoster Treatment Market Size (2019-2030)
7.2 Europe Herpes Zoster Treatment Market Size by Type
7.2.1 Europe Herpes Zoster Treatment Market Size by Type (2019-2024)
7.2.2 Europe Herpes Zoster Treatment Market Size by Type (2025-2030)
7.2.3 Europe Herpes Zoster Treatment Market Share by Type (2019-2030)
7.3 Europe Herpes Zoster Treatment Market Size by Application
7.3.1 Europe Herpes Zoster Treatment Market Size by Application (2019-2024)
7.3.2 Europe Herpes Zoster Treatment Market Size by Application (2025-2030)
7.3.3 Europe Herpes Zoster Treatment Market Share by Application (2019-2030)
7.4 Europe Herpes Zoster Treatment Market Size by Country
7.4.1 Europe Herpes Zoster Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Herpes Zoster Treatment Market Size by Country (2019-2024)
7.4.3 Europe Herpes Zoster Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Herpes Zoster Treatment Market Size (2019-2030)
8.2 China Herpes Zoster Treatment Market Size by Type
8.2.1 China Herpes Zoster Treatment Market Size by Type (2019-2024)
8.2.2 China Herpes Zoster Treatment Market Size by Type (2025-2030)
8.2.3 China Herpes Zoster Treatment Market Share by Type (2019-2030)
8.3 China Herpes Zoster Treatment Market Size by Application
8.3.1 China Herpes Zoster Treatment Market Size by Application (2019-2024)
8.3.2 China Herpes Zoster Treatment Market Size by Application (2025-2030)
8.3.3 China Herpes Zoster Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Herpes Zoster Treatment Market Size (2019-2030)
9.2 Asia Herpes Zoster Treatment Market Size by Type
9.2.1 Asia Herpes Zoster Treatment Market Size by Type (2019-2024)
9.2.2 Asia Herpes Zoster Treatment Market Size by Type (2025-2030)
9.2.3 Asia Herpes Zoster Treatment Market Share by Type (2019-2030)
9.3 Asia Herpes Zoster Treatment Market Size by Application
9.3.1 Asia Herpes Zoster Treatment Market Size by Application (2019-2024)
9.3.2 Asia Herpes Zoster Treatment Market Size by Application (2025-2030)
9.3.3 Asia Herpes Zoster Treatment Market Share by Application (2019-2030)
9.4 Asia Herpes Zoster Treatment Market Size by Region
9.4.1 Asia Herpes Zoster Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Herpes Zoster Treatment Market Size by Region (2019-2024)
9.4.3 Asia Herpes Zoster Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Herpes Zoster Treatment Introduction
11.1.4 Roche Revenue in Herpes Zoster Treatment Business (2019-2024)
11.1.5 Roche Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Herpes Zoster Treatment Introduction
11.2.4 Novartis Revenue in Herpes Zoster Treatment Business (2019-2024)
11.2.5 Novartis Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Herpes Zoster Treatment Introduction
11.3.4 Merck Revenue in Herpes Zoster Treatment Business (2019-2024)
11.3.5 Merck Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Herpes Zoster Treatment Introduction
11.4.4 GlaxoSmithKline Revenue in Herpes Zoster Treatment Business (2019-2024)
11.4.5 GlaxoSmithKline Recent Developments
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Herpes Zoster Treatment Introduction
11.5.4 Abbott Laboratories Revenue in Herpes Zoster Treatment Business (2019-2024)
11.5.5 Abbott Laboratories Recent Developments
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Details
11.6.2 Astellas Pharma Business Overview
11.6.3 Astellas Pharma Herpes Zoster Treatment Introduction
11.6.4 Astellas Pharma Revenue in Herpes Zoster Treatment Business (2019-2024)
11.6.5 Astellas Pharma Recent Developments
11.7 Bausch Health Companies
11.7.1 Bausch Health Companies Company Details
11.7.2 Bausch Health Companies Business Overview
11.7.3 Bausch Health Companies Herpes Zoster Treatment Introduction
11.7.4 Bausch Health Companies Revenue in Herpes Zoster Treatment Business (2019-2024)
11.7.5 Bausch Health Companies Recent Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Herpes Zoster Treatment Introduction
11.8.4 Teva Pharmaceutical Revenue in Herpes Zoster Treatment Business (2019-2024)
11.8.5 Teva Pharmaceutical Recent Developments
11.9 Foamix Pharmaceuticals
11.9.1 Foamix Pharmaceuticals Company Details
11.9.2 Foamix Pharmaceuticals Business Overview
11.9.3 Foamix Pharmaceuticals Herpes Zoster Treatment Introduction
11.9.4 Foamix Pharmaceuticals Revenue in Herpes Zoster Treatment Business (2019-2024)
11.9.5 Foamix Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Herpes Zoster Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Oral
Table 3. Key Players of Topical
Table 4. Key Players of Others
Table 5. Global Herpes Zoster Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Herpes Zoster Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Herpes Zoster Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Herpes Zoster Treatment Market Share by Region (2019-2024)
Table 9. Global Herpes Zoster Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Herpes Zoster Treatment Market Share by Region (2025-2030)
Table 11. Herpes Zoster Treatment Market Trends
Table 12. Herpes Zoster Treatment Market Drivers
Table 13. Herpes Zoster Treatment Market Challenges
Table 14. Herpes Zoster Treatment Market Restraints
Table 15. Global Herpes Zoster Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Herpes Zoster Treatment Revenue Share by Players (2019-2024)
Table 17. Global Top Herpes Zoster Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Zoster Treatment as of 2023)
Table 18. Global Herpes Zoster Treatment Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Herpes Zoster Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Herpes Zoster Treatment, Headquarters and Area Served
Table 21. Global Key Players of Herpes Zoster Treatment, Product and Application
Table 22. Global Key Players of Herpes Zoster Treatment, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Herpes Zoster Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Herpes Zoster Treatment Revenue Market Share by Type (2019-2024)
Table 26. Global Herpes Zoster Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Herpes Zoster Treatment Revenue Market Share by Type (2025-2030)
Table 28. Global Herpes Zoster Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Herpes Zoster Treatment Revenue Share by Application (2019-2024)
Table 30. Global Herpes Zoster Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Herpes Zoster Treatment Revenue Share by Application (2025-2030)
Table 32. North America Herpes Zoster Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Herpes Zoster Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Herpes Zoster Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Herpes Zoster Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Herpes Zoster Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Herpes Zoster Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Herpes Zoster Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Herpes Zoster Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Herpes Zoster Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Herpes Zoster Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Herpes Zoster Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Herpes Zoster Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Herpes Zoster Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Herpes Zoster Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Herpes Zoster Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Herpes Zoster Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Herpes Zoster Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Herpes Zoster Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Herpes Zoster Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Herpes Zoster Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Herpes Zoster Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Herpes Zoster Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Herpes Zoster Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Herpes Zoster Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Herpes Zoster Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Herpes Zoster Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 64. Roche Company Details
Table 65. Roche Business Overview
Table 66. Roche Herpes Zoster Treatment Product
Table 67. Roche Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)
Table 68. Roche Recent Developments
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Herpes Zoster Treatment Product
Table 72. Novartis Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)
Table 73. Novartis Recent Developments
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Herpes Zoster Treatment Product
Table 77. Merck Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)
Table 78. Merck Recent Developments
Table 79. GlaxoSmithKline Company Details
Table 80. GlaxoSmithKline Business Overview
Table 81. GlaxoSmithKline Herpes Zoster Treatment Product
Table 82. GlaxoSmithKline Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)
Table 83. GlaxoSmithKline Recent Developments
Table 84. Abbott Laboratories Company Details
Table 85. Abbott Laboratories Business Overview
Table 86. Abbott Laboratories Herpes Zoster Treatment Product
Table 87. Abbott Laboratories Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)
Table 88. Abbott Laboratories Recent Developments
Table 89. Astellas Pharma Company Details
Table 90. Astellas Pharma Business Overview
Table 91. Astellas Pharma Herpes Zoster Treatment Product
Table 92. Astellas Pharma Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)
Table 93. Astellas Pharma Recent Developments
Table 94. Bausch Health Companies Company Details
Table 95. Bausch Health Companies Business Overview
Table 96. Bausch Health Companies Herpes Zoster Treatment Product
Table 97. Bausch Health Companies Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)
Table 98. Bausch Health Companies Recent Developments
Table 99. Teva Pharmaceutical Company Details
Table 100. Teva Pharmaceutical Business Overview
Table 101. Teva Pharmaceutical Herpes Zoster Treatment Product
Table 102. Teva Pharmaceutical Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)
Table 103. Teva Pharmaceutical Recent Developments
Table 104. Foamix Pharmaceuticals Company Details
Table 105. Foamix Pharmaceuticals Business Overview
Table 106. Foamix Pharmaceuticals Herpes Zoster Treatment Product
Table 107. Foamix Pharmaceuticals Revenue in Herpes Zoster Treatment Business (2019-2024) & (US$ Million)
Table 108. Foamix Pharmaceuticals Recent Developments
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Herpes Zoster Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Herpes Zoster Treatment Market Share by Type: 2023 VS 2030
Figure 3. Oral Features
Figure 4. Topical Features
Figure 5. Others Features
Figure 6. Global Herpes Zoster Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Herpes Zoster Treatment Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Home Care Settings Case Studies
Figure 11. Herpes Zoster Treatment Report Years Considered
Figure 12. Global Herpes Zoster Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Herpes Zoster Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Herpes Zoster Treatment Market Share by Region: 2023 VS 2030
Figure 15. Global Herpes Zoster Treatment Market Share by Players in 2023
Figure 16. Global Top Herpes Zoster Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Zoster Treatment as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Herpes Zoster Treatment Revenue in 2023
Figure 18. North America Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Herpes Zoster Treatment Market Share by Type (2019-2030)
Figure 20. North America Herpes Zoster Treatment Market Share by Application (2019-2030)
Figure 21. North America Herpes Zoster Treatment Market Share by Country (2019-2030)
Figure 22. United States Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Herpes Zoster Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 25. Europe Herpes Zoster Treatment Market Share by Type (2019-2030)
Figure 26. Europe Herpes Zoster Treatment Market Share by Application (2019-2030)
Figure 27. Europe Herpes Zoster Treatment Market Share by Country (2019-2030)
Figure 28. Germany Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. China Herpes Zoster Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 35. China Herpes Zoster Treatment Market Share by Type (2019-2030)
Figure 36. China Herpes Zoster Treatment Market Share by Application (2019-2030)
Figure 37. Asia Herpes Zoster Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 38. Asia Herpes Zoster Treatment Market Share by Type (2019-2030)
Figure 39. Asia Herpes Zoster Treatment Market Share by Application (2019-2030)
Figure 40. Asia Herpes Zoster Treatment Market Share by Region (2019-2030)
Figure 41. Japan Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. South Korea Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Taiwan Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. India Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Australia Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Share by Type (2019-2030)
Figure 49. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Share by Application (2019-2030)
Figure 50. Middle East, Africa, and Latin America Herpes Zoster Treatment Market Share by Country (2019-2030)
Figure 51. Brazil Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Mexico Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Turkey Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Israel Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. GCC Countries Herpes Zoster Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Roche Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)
Figure 58. Novartis Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)
Figure 59. Merck Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)
Figure 61. Abbott Laboratories Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)
Figure 62. Astellas Pharma Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)
Figure 63. Bausch Health Companies Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)
Figure 64. Teva Pharmaceutical Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)
Figure 65. Foamix Pharmaceuticals Revenue Growth Rate in Herpes Zoster Treatment Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies